ALL KEYWORDSFibrocystic Liver DiseaseRelated SpecialistsShowing 3 of 5Marina SilveiraMDAriel JaffeMDMichael SchilskyMDMore Related SpecialistsRelated Clinical TrialsA Phase 3 Study Evaluating Long-term Efficacy and Safety of Lanifibranor in Adult Patients With (NASH) and Fibrosis 2 (F2)/Fibrosis 3 (F3) Stage of Liver Fibrosis (NATiV3)LiverGender:All GendersAge:18 years and olderPathophysiology of Nonalcoholic Fatty Liver Disease (NAFLD) in Youth with ObesityDiabetesLiverEndocrine SystemObesity & Weight ManagementGender:All GendersAge:12 years - 22 years
